© 1999 by Oxford University Press
Journal of the National Cancer Institute, Vol. 91, No. 6, 504-505,
March 17, 1999
© 1999 Oxford University Press
NEWS |
Awards, Appointments, Announcements
Columbia University, New York, awarded the 1998 Louisa Gross Horwitz Prize to Bert Vogelstein, M.D., Howard Hughes medical investigator and Clayton Professor of Oncology at the Johns Hopkins Medical Institutions, Baltimore. Vogelstein received the award last month for his "groundbreaking discoveries in the genetic basis of colon cancer."
|
The Louisa Gross Horwitz Prize is awarded annually for outstanding basic research in biology or biochemistry. The announcement said that the prize's purpose "is to honor a scientific investigator or group of investigators whose contributions to knowledge in either of these fields is deemed worthy of special recognition."
DeBor Named EVP
AMDeC, New York, an American Medicine Development Company, named Marydale DeBor as executive vice president of the AMDeC Foundation. The company is a partnership of 23 academic medical and health care institutions in New York.
DeBor is an attorney who also has advised corporate and private foundation clients on philanthropic investment strategies. AMDeC was formed 2 years ago to "expand New York City's role as the international capital of the biomedical research and technology industry over the course of the next decade."
RPCI Appoints Staff
The Roswell Park Cancer Institute, Buffalo, announced that it appointed new faculty members in its Division of Medicine and its Division of Surgery's Department of Urologic Oncology.
RPCI said it named Harish Ahuja, M.D., as a staff member in the Division of Medicine's Leukemia Section. It named David A. Corral, M.D., to the staff of the Department of Urologic Oncology.
|
|
ISIS Names Blank
ISIS Pharmaceuticals, Carlsbad, Calif., named Debbie Jo Blank, M.D., as executive vice president. She will oversee corporate development, business development, strategic planning and marketing, human resources and operations, and investor relations.
Blank had been president and chief operating officer with Cypress Bioscience, Inc., San Diego. Other ISIS executives include F. Andrew Dorr, M.D., vice president for development, who will continue to manage the company's cancer program and will assume responsibility for its antiviral program and its statistics and data management department.
Ohio Name Change
The Ohio State University Board of Trustees recently approved the addition of Richard J. Solove's name to the name of its hospital and research institute. The new name is Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
Solove, a real estate developer in Columbus, Ohio, recently gave $20 million toward cancer genetics research at the institution. He also is a member of the board of the hospital and was a founder of the James Foundation Board. He has been associated with Arthur G. James, M.D., since 1953.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||